Business
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET
DALLAS, March 20, 2025--Q4 & Fiscal Year 2024 Earnings Call Save The Date
About this update from Lantern Pharma Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/fa6e8f87c5b899f203fac2f1eed317cd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8sIJhkfy8tkJp2Rx9yyYcA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/fa6e8f87c5b899f203fac2f1eed317cd","width":480,"height":480}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Webcast to be held Thursday, March 27th, 4:30 p.m. ET, register for the webcast here, or at the link provided below.","length":116,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":116,"olType":false},{"type":"text","content":"DALLAS, March 20, 2025--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning ("ML") platform with multiple clinical stage drug programs, today announced that it will host its fourth quarter and fiscal year 2024 operating and financial results webcast on Thursday, March 27, 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.","length":492,"tagName":"p"},{"type":"text","content":"Management intends to discuss the operating and financial results for the fourth quarter and fiscal year ended December 31, 2024 and provide guidance on upcoming milestones, clinical trials and developments of the AI platform, RADR®. Panna Sharma, President and Chief Executive Officer of Lantern Pharma, will lead the call and will be joined by other members of the management team.","length":383,"tagName":"p"},{"type":"text","content":"To register for the webinar, please sign up at the Zoom webcast link provided in the link: Lantern Pharma Q4, 2024 earnings Zoom webcast registration link. A replay of the earnings call webcast will be available after the call on the investor relations section of the Company's website: ir.lanternpharma.com.","length":312,"tagName":"p"},{"type":"text","content":"About Lantern Pharma","length":20,"tagName":"p"},{"type":"text","content":"Lantern Pharma (NASDAQ: LTRN) is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary A...